PRESS RELEASE published on 09/29/2025 at 21:48, 2 months 5 days ago rapport financier semestriel 2025
BRIEF published on 08/28/2025 at 20:05, 3 months 7 days ago GenSight Biologics reporte la publication de ses résultats financiers semestriels 2025 Résultats Financiers Conformité Réglementaire Report GenSight Biologics Procédures D'audit
BRIEF published on 08/28/2025 at 20:05, 3 months 7 days ago GenSight Biologics Delays 2025 Half-Year Financial Results Announcement Financial Results Regulatory Compliance Postponement GenSight Biologics Audit Procedures
PRESS RELEASE published on 08/28/2025 at 20:00, 3 months 7 days ago Informations privilégiées / Autres communiqués GenSight Biologics reporte la publication de ses résultats financiers semestriels 2025. Le report est dû à l'audit en cours, non lié à des problèmes financiers. Réunions importantes reprogrammées Résultats Financiers Communication Financière Audit Report GenSight Biologics
PRESS RELEASE published on 08/28/2025 at 20:00, 3 months 7 days ago Inside Information / Other news releases GenSight Biologics postpones the release of its 2025 half-year financial results to September 29, 2025, after the market closes, to ensure highest audit standards. No material issues reported. Audit Committee and Board meetings rescheduled Financial Results Transparency Postponement GenSight Biologics Audit Procedures
BRIEF published on 07/17/2025 at 15:05, 4 months 18 days ago GenSight Biologics : publication d'un article sur les prédictions de la thérapie génique LUMEVOQ® Thérapie Génique GenSight Biologics NOHL LUMEVOQ Acuité Visuelle
BRIEF published on 07/17/2025 at 15:05, 4 months 18 days ago GenSight Biologics: Publication of an article on the predictions of LUMEVOQ® gene therapy Gene Therapy GenSight Biologics NOHL LUMEVOQ Visual Acuity
PRESS RELEASE published on 07/17/2025 at 15:00, 4 months 18 days ago Inside Information / Other news releases GenSight Biologics announces publication on predictors of final visual outcome in patients treated with LUMEVOQ® gene therapy. Study identifies key factors for improved visual acuity post-treatment Gene Therapy GenSight Biologics LUMEVOQ Visual Outcome Predictive Factors
PRESS RELEASE published on 07/17/2025 at 15:00, 4 months 18 days ago Informations privilégiées / Autres communiqués GenSight Biologics annonce la publication d'un article sur les facteurs prédictifs du résultat visuel final chez les patients traités par la thérapie génique LUMEVOQ® Thérapie Génique GenSight Biologics LUMEVOQ Facteurs Prédictifs Résultat Visuel Final
BRIEF published on 07/17/2025 at 08:05, 4 months 19 days ago GenSight Biologics raises 500,000 euros to strengthen its development Funding GenSight Biologics Phase III Gene Therapies LUMEVOQ
Published on 12/05/2025 at 02:35, 10 hours ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 11 hours 35 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 13 hours 30 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 13 hours 35 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 12:05, 29 minutes ago Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 34 minutes ago CGTN：Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre
Published on 12/05/2025 at 12:00, 35 minutes ago Iute Group: Successful Issue of Additional EUR 2025/2030 Bonds – Circulating Volume Increased to EUR 160 Million
Published on 12/05/2025 at 11:14, 1 hour 20 minutes ago Halfords Group PLC: Director/PDMR Shareholding
Published on 12/05/2025 at 11:08, 1 hour 26 minutes ago Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 12/05/2025 at 08:45, 3 hours 50 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 3 hours 50 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 3 hours 52 minutes ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 18 hours 20 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 18 hours 35 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
